GOLDEN, Colo., May 1, 2023 — Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea” or the “Company”), a Colorado-based manufacturing, research, and product development company in the natural health and wellness industry, is conducting research and formulation design for product development expansion in the fast-growing mushroom category.
Amanita muscaria products are in high demand and one of the most searched natural products on the internet, eclipsing other natural sources for healing and inebriation. However, current knowledge on the chemistry, toxicology, and biology relating to this mushroom, also known as “Fly Agaric” is not well known. The mushroom contains psychoactive compounds that has been used as an analgesic, ant-inflammatory, anxiolytic at various doses as well as in increasing concentrations to produce altered states of consciousness or inebriation. Due to its varied properties Amanita muscaria has been historically used by medicine men or shamans to heal, increase strength and endurance and induce a trance-like state.
The Amanita muscaria grows wild throughout continental Europe and the UK from July to October. The three identified psychogenic compounds in the mushroom are ibotenic acid, muscarine, and muscimol. The molecular pharmacology of each compound has been described as “psychoactive” to produce sedative and hallucinogenic properties but have also been reported to induce nausea unless purified to remove other alkaloids in the mushroom when consumed orally. The ratios and formulations of these three compounds as well as other mushroom extracts needed to produce beneficial effects and avoid deleterious side effects such as nausea are not currently known. Due to its reported healing and inebriation qualities, many companies have launched products containing Amanita muscaria on the internet. Through Panacea’s internal testing protocols, we have determined that many of these products do not contain any Amanita extract and are in effect selling misleading products.
Panacea Life Sciences is in the late stages of launching two high quality-controlled products in both a gummy and soft gel form to allow consumers to reduce anxiety, enhance mood, produce a great night’s sleep, and inebriation at elevated doses. Panacea Life Science’s initial Amanita products will be launched this month and provide a new natural product for consumers. The Panacea mushroom products will provide the Panacea reliability and quality control that is unparalleled in this space.
Products containing Amanita muscaria are an expansion of Panacea Life Science’s natural healing portfolio. In order to bring these high-quality products to consumers, Panacea has secured the supply chain of highly potent Amanita muscaria biomass, have worked to optimize extraction of biomass, and has engaged Panacea Life Science’s Cannabinoid Research Center at Colorado State University to provide unparalleled quantification of active ingredients in Amanita muscaria. Panacea’s proprietary distillation process retains the restorative and healing element from the Amanita mushroom and removes toxins to make products safe for consumption.
You may also like: A Beginner’s Guide to Amanita muscaria Mushrooms
